{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T23:40:01Z","timestamp":1748130001812,"version":"3.41.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.clinre.2025.102551","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T17:13:23Z","timestamp":1738862003000},"page":"102551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of portal hypertension in patients with hepatocellular carcinoma"],"prefix":"10.1016","volume":"49","author":[{"given":"Fran\u00e7ois","family":"Faitot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinre.2025.102551_bib0001","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ueg2.12188","article-title":"Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. United","volume":"10","author":"M\u00fcller","year":"2021","journal-title":"Eur Gastroenterol J"},{"issue":"1","key":"10.1016\/j.clinre.2025.102551_bib0002","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hep.27864","article-title":"Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation","volume":"62","author":"Faitot","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clinre.2025.102551_bib0003","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102551_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102496","article-title":"Non selective beta-blockers prevent PHT-related complications occurrence in HCC patients with esophageal varices treated by TACE","volume":"49","author":"Allaire","year":"2025","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2025.102551_bib0005","doi-asserted-by":"crossref","first-page":"12781","DOI":"10.3389\/ti.2024.12781","article-title":"Transjugular intrahepatic portosystemic shunt is associated with better waitlist management of liver transplant candidates with Hepatocellular Carcinoma","volume":"37","author":"El Hajji","year":"2024","journal-title":"Transpl Int"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125000312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125000312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T23:05:09Z","timestamp":1748127909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740125000312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2210740125000312"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102551","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of portal hypertension in patients with hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102551"}}